One of these truncated variants of CARD9 (S12NΔ11 or CARD9Δ11) is strongly associated with protection against IBD, which is mechanistically linked to the inability of these variants to be activated by TRIM62, a ubiquitin ligase that is required for CARD9 activation and subsequent pro-inflammatory cytokine production. Here, TRIM62 is linked to inflammatory bowel disease.